Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections
May 2000
The FDA just approved Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections.
Zyvox is the first in a new class...oxazolidinones. It works by inhibiting bacterial protein synthesis.
It will be used for certain gram-positive infections...including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote